A validated UPLC–MS/MS method for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma

por Zeng, Jing, Cai, Hua lin, Jiang, Zhi ping, Wang, Qing, Zhu, Yan, Xu, Ping, Zhao, Xie lan
Publicado 2017

PTEN Regulates BCRP/ABCG2 and the Side Population through the PI3K/Akt Pathway in Chronic Myeloid Leukemia

por Huang, Fang-Fang, Zhang, Li, Wu, Deng-Shu, Yuan, Xiao-Yu, Chen, Fang-Ping, Zeng, Hui, Yu, Yan-Hui, Zhao, Xie-Lan
Publicado 2014

CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia

por Liu, Wei, Yi, Jin-Mou, Liu, Yi, Chen, Cong, Zhang, Kai-Xuan, Zhou, Cheng, Zhan, Hui-En, Zhao, Liang, Morales, Stephanie, Zhao, Xie-Lan, Zeng, Hui
Publicado 2021

Roles of hsa-miR-12462 and SLC9A1 in acute myeloid leukemia

por Jia, Yan, Liu, Wei, Zhan, Hui-En, Yi, Xiao-Ping, Liang, Hui, Zheng, Qi-Li, Jiang, Xin-Ya, Zhou, Hai-Yan, Zhao, Liang, Zhao, Xie-Lan, Zeng, Hui
Publicado 2020

Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens

por Chen, Peng, Zhu, Ke-Wei, Zhang, Dao-Yu, Yan, Han, Liu, Han, Liu, Yan-Ling, Cao, Shan, Zhou, Gan, Zeng, Hui, Chen, Shu-Ping, Zhao, Xie-Lan, Yang, Jing, Chen, Xiao-Ping
Publicado 2018

Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML)

por Zhu, Ke-Wei, Chen, Peng, Zhang, Dao-Yu, Yan, Han, Liu, Han, Cen, Li-Na, Liu, Yan-Ling, Cao, Shan, Zhou, Gan, Zeng, Hui, Chen, Shu-Ping, Zhao, Xie-Lan, Chen, Xiao-Ping
Publicado 2018

Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients

por Yuan, Xiao-Qing, Chen, Peng, Du, Yin-Xiao, Zhu, Ke-Wei, Zhang, Dao-Yu, Yan, Han, Liu, Han, Liu, Yan-Ling, Cao, Shan, Zhou, Gan, Zeng, Hui, Chen, Shu-Ping, Zhao, Xie-Lan, Yang, Jing, Zeng, Wen-Jing, Chen, Xiao-Ping
Publicado 2019